Your browser doesn't support javascript.
loading
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
Ramos-Casals, Manuel; Brito-Zerón, Pilar; Bombardieri, Stefano; Bootsma, Hendrika; De Vita, Salvatore; Dörner, Thomas; Fisher, Benjamin A; Gottenberg, Jacques-Eric; Hernandez-Molina, Gabriela; Kocher, Agnes; Kostov, Belchin; Kruize, Aike A; Mandl, Thomas; Ng, Wan-Fai; Retamozo, Soledad; Seror, Raphaèle; Shoenfeld, Yehuda; Sisó-Almirall, Antoni; Tzioufas, Athanasios G; Vitali, Claudio; Bowman, Simon; Mariette, Xavier.
Affiliation
  • Ramos-Casals M; Department of Autoimmune Diseases, Hospital Clinic de Barcelona Institut Clinic de Medicina i Dermatologia, Barcelona, Catalunya, Spain mramos@clinic.cat.
  • Brito-Zerón P; CELLEX, Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Barcelona, Catalunya, Spain.
  • Bombardieri S; CELLEX, Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Barcelona, Catalunya, Spain.
  • Bootsma H; Autoimmune Diseases Unit, Department of Internal Medicine, Hospital CIMA Sanitas, Barcelona, Catalunya, Spain.
  • De Vita S; Rheumatology Unit, University of Pisa, Pisa, Toscana, Italy.
  • Dörner T; Department of Rheumatology & Clinical Immunology, University of Groningen, Groningen, Groningen, The Netherlands.
  • Fisher BA; Clinic of Rheumatology, University Hospital Santa Maria della Misericordia, Udine, Italy.
  • Gottenberg JE; Department of Medicine/Rheumatology and Clinical Immunology and DRFZ, Charite University Hospital Berlin, Berlin, Germany.
  • Hernandez-Molina G; Institute of Inflammation and Aging, University of Birmingham, Birmingham, UK.
  • Kocher A; National Institute of Health Research Birmingham Biomedical Centre and Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Kostov B; Department of Rheumatology, Strasbourg University Hospital, National Reference Center for Rare Systemic Autoimmune Diseases, CNRS, IBMC, UPR 3572, Université de Strasbourg, Strasbourg, Alsace, France.
  • Kruize AA; Immunology and Rheumatology Department, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico.
  • Mandl T; Institute of Nursing Science, Department of Public Health, Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Ng WF; Department of Rheumatology, Immunology and Allergology, Inselspital, University Hospital of Bern, Bern, Switzerland.
  • Retamozo S; Primary Healthcare Transversal Research Group, IDIBAPS, Barcelona, Catalunya, Spain.
  • Seror R; Department of Statistics and Operations Research, Universitat Politecnica de Catalunya, Barcelona, Catalunya, Spain.
  • Shoenfeld Y; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sisó-Almirall A; Department of Rheumatology, Skane University Hospital Malmö, Lund University, Lund, Sweden.
  • Tzioufas AG; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Vitali C; NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne NHS Foundation Trust, Newcastle Upon Tyne, Tyne and Wear, UK.
  • Bowman S; Rheumatology Unit. Instituto Modelo de Cardiología Privado SRL, Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba, Argentina.
  • Mariette X; Instituto de Investigaciones en Ciencias de la Salud, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Universidad Nacional de Córdoba, Cordoba, Córdoba, Argentina.
Ann Rheum Dis ; 79(1): 3-18, 2020 01.
Article in En | MEDLINE | ID: mdl-31672775

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Saliva, Artificial / Sjogren's Syndrome / Muscarinic Agonists / Antirheumatic Agents / Lubricant Eye Drops / Glucocorticoids / Immunosuppressive Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2020 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Saliva, Artificial / Sjogren's Syndrome / Muscarinic Agonists / Antirheumatic Agents / Lubricant Eye Drops / Glucocorticoids / Immunosuppressive Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2020 Type: Article Affiliation country: Spain